Last reviewed · How we verify
NCT05994586
The Efficacy of AP029 Mix in Patients With Impaired Carbohydrate Metabolism
NA trial testing AP029 mix in Diabetes in Adolescence in 30 participants. Status unknown.
26 November 2023
Quick facts
| Lead sponsor | AronPharma Sp. z o. o. |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 30 |
| Start date | 25 May 2023 |
| Primary completion | 26 November 2023 |
| Estimated completion | 26 November 2023 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- AP029 mix
- Placebo
Conditions studied
- Diabetes in Adolescence — all drugs for Diabetes in Adolescence →
- PreDiabetes — all drugs for PreDiabetes →
Sponsor
AronPharma Sp. z o. o.
Who can join
Adults 18 to 75, any sex, with Diabetes in Adolescence or PreDiabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to demonstrate that a daily supplementation of AP029 Mix: I) has a positive effect on reducing side effects of metformin, while enhancing the therapeutic effect of metformin; II) normalizes prediabetes biomarkers in order to prevent further progression into diabetes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Development of Potential Therapeutic Agents from Black Elderberries (the Fruits of <i>Sambucus nigra</i> L.).
Ren Y, Meyer G, Anderson AT, Lauber KM, et al · · 2024 · cited 2× · PMID 38998923 · DOI 10.3390/molecules29132971
Verify or expand the search:
- PubMed search for NCT05994586
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes in Adolescence
Currently open trials in the same condition.
- NCT05277558 — Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D) · recruiting
Other AronPharma Sp. z o. o. trials
Trials by the same sponsor.
- NCT06017661 — Investigation of a Polyphenol-rich Preparation as Support for Oncology Patients Undergoing Gastrointestinal Tumor Resect · NA · unknown
- NCT05994638 — Polyphenol Rich Aerosol as a Support for Cancer Patients in Minimizing Side Effects After a Radiation Therapy · NA · unknown
- NCT06004570 — Effects of a Combination of Polyphenol-rich Extracts on the Protection of Retinal Cells Against Blue Light in the Preven · NA · completed
- NCT05990764 — Effects of a Combination of Polyphenol-rich Extracts, Prebiotics, and Hydrolyzed Fiber on the Quality of Life of Patient · NA · unknown
- NCT05988099 — Comparison of the Effects of Standardized Chokeberry Extracts With Various Formulations on the Levels of Selected Marker · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05994586 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by AronPharma Sp. z o. o.
- Last refreshed: 16 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05994586.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing